Understanding Lab Results and Genetic Reports

Understanding your child’s diagnostic reports is a powerful way to advocate for their care. Because DHFR deficiency is an “ultra-rare” condition, the diagnosis usually involves a combination of looking at the shape of blood cells, checking specific chemical markers, and finally confirming the genetic “code” ^[1].

Always keep in mind that pediatric Complete Blood Count (CBC) and biochemical values must be interpreted using age-specific laboratory ranges, and these numbers will shift if your child has recently received a blood transfusion or started treatment.

Decoding Your Child’s Lab Reports

When you look at your child’s blood work, you may see several technical terms that describe the size and health of their blood cells.

Key Technical Terms

1. Megaloblastic Anemia: A type of anemia where the bone marrow produces red blood cells that are unusually large and immature because they cannot copy their DNA correctly ^[1][2].
2. Macrocytosis: This simply means “large cells.” On a report, you will see a high MCV (Mean Corpuscular Volume), which is the measurement of the average size of red blood cells ^[2].
3. Pancytopenia: This indicates that all three main types of blood cells—red cells, white cells, and platelets—are lower than normal ^[3][4].
4. Pathogenic Variants: Genetic mutations that have been scientifically classified as disease-causing.
5. Biallelic / In Trans: This means changes were found in both copies of the DHFR gene—one inherited from each parent, sitting on opposite copies of the chromosome ^[1]. (If a report says “compound heterozygous,” it means the two pathogenic variants found are different from one another, but both are present).
6. Macro-ovalocytes and Hypersegmented Neutrophils: When a pathologist looks at a peripheral blood smear under a microscope, they may see unusually large, oval-shaped red blood cells (macro-ovalocytes) and white blood cells with too many segments in their center (hypersegmented neutrophils) ^[2].

The Chemical “Signature”

Doctors use specific chemical markers to help distinguish DHFR deficiency from other conditions that look similar, such as Vitamin B12 processing defects ^[5].

• Total Homocysteine (tHcy): In DHFR deficiency, this marker is often elevated. Homocysteine builds up when the folate processing pathway is blocked ^[5][6].
• Methylmalonic Acid (MMA): This is a key differentiator. In DHFR deficiency, the MMA level is typically normal. If the MMA were high, it would point toward a B12-related disorder instead ^[5][7].

Decoding the Diagnostic Workup

To ensure the diagnosis is as accurate as possible, your medical records will likely contain data from the following areas. These are excellent topics to bring up with your metabolic specialist.

1. Hematology (Blood) Markers

• MCV (Mean Corpuscular Volume): To evaluate for macrocytosis.
• Reticulocyte Count: To see how many new red blood cells the marrow is attempting to make.
• Blood Smear Review: A manual microscopic check for macro-ovalocytes or hypersegmented neutrophils.

2. Metabolic (Chemical) Markers

• Plasma Total Homocysteine: Typically high in DHFR deficiency.
• Serum Methylmalonic Acid (MMA): Expected to be normal (supports ruling out B12 defects).
• Serum B12 and Folate Levels: To evaluate for simple nutritional deficiencies.

3. Molecular (Genetic) Testing

• Gene Name: Must specifically list the DHFR gene.
• Variant Nomenclature: The specific “typos” in the gene (e.g., p.Gly18Val).
• Classification: Confirming the variants are “pathogenic” or “likely pathogenic,” not just “variants of uncertain significance” (VUS).
• Parental Segregation (Optional but helpful): Testing of the parents to confirm that each parent carried one of the variants, proving the child’s mutations are “in trans” (on separate copies of the gene).

4. Specialized Testing (Only if Indicated)

• CSF 5-MTHF: In highly specific cases, a neurologist or metabolic specialist may recommend testing the spinal fluid (via lumbar puncture) for the level of active folate in the brain ^[8][9]. This is an invasive test and is not mandatory for every patient; it should only be considered if the specialist believes it will directly change your child’s treatment plan.